Objectives To explore the feasibility of diffusion-weighted imaging (DWI) to assess inflammatory lung changes in patients with Cystic Fibrosis (CF) Methods CF patients referred for their annual check-up had spirometry, chest-CT and MRI on the same day. MRI was performed in a 1.5 T scanner with BLADE and EPI-DWI sequences (b = 0-600 s/mm 2 ). End-inspiratory and endexpiratory scans were acquired in multi-row scanners. DWI was scored with an established semi-quantitative scoring system. DWI score was correlated to CT sub-scores for bronchiectasis (CF-CT BE ), mucus (CF-CT mucus ), total score (CF-CT total-score ), FEV 1 , and BMI. T-test was used to assess differences between patients with and without DWI-hotspots. Results Thirty-three CF patients were enrolled (mean 21 years, range 6-51, 19 female). 4 % (SD 2.6, range 1.5-12.9) of total CF-CT alterations presented DWI-hotspots. DWI-hotspots coincided with mucus plugging (60 %), consolidation (30 %) and bronchiectasis (10 %). DWI total-score correlated (all p < 0.0001) positively to CF-CT BE (r = 0.757), CF-CT mucus (r = 0.759) and CF-CT total-score (r = 0.79); and negatively to FEV 1 (r = 0.688). FEV 1 was significantly higher (p < 0.0001) in patients without DWI-hotspots. Conclusions DWI-hotspots strongly correlated with radiological and clinical parameters of lung disease severity. Future validation studies are needed to establish the exact nature of DWI-hotspots in CF patients. Key Points • DWI hotspots only partly overlapped structural abnormalities on morphological imaging • DWI strongly correlated with radiological and clinical indicators of CF-disease severity • Patients with more DWI hotspots had lower lung function values • Mucus score best predicted the presence of DWI-hotspots with restricted diffusion.
Introduction
Cystic Fibrosis (CF) lung disease is characterized by chronic airways infection, inflammation, and progressive lung damage starting in early childhood [1] . Exacerbations, and acute episodes of infection and inflammation, eventually lead to endstage lung disease, the main cause of death in patients with CF [2] . Regular monitoring that includes a physical examination, spirometry, quality-of-life questionnaires and imaging [3] , is used to detect lung changes that require timely treatment [4] .
To date, imaging techniques such as chest x-ray (CXR) and chest-CT (CT) have been the preferred methods for CF monitoring; however, both techniques have limitations [5] . CXR only allows detection of gross lung changes, such as consolidation, atelectasis, and pleural effusion [5] . CT is far more sensitive to localize and quantify structural changes [6] ; however, short-term follow-up with CT, for example during an exacerbation, is restricted by radiation exposure [7] . The latter limitation was the driving force to introduce MRI in CF lung monitoring [8] . Unfortunately, MRI has inferior sensitivity compared to CT to detect structural changes in the CF lung [9, 10] due to a lower spatial resolution. However, more recently the resolution has improved by using newly developed sequences, such as ultrashort [11] or zero echo time [12] . Furthermore, the interest for using MRI in CF has expanded towards functional imaging [13] . Multi-parametric MRI, such as Fourier Decomposition [14] , hyperpolarized-gases MRI, and oxygen-enhanced MRI [15, 16] , provide information not readily available with CT [17] . Diffusion-weighted imaging (DWI) is another MRI technique that might have great potential in CF lung monitoring [18] . To date, DWI has been primarily used to assess malignancies in thoracic imaging [19] . Interestingly, DWI has proved to be accurate in the identification of inflammation in various organs, such as brain, spine, muscle, and intestines [20] [21] [22] [23] . Based on these studies, we investigated whether DWI has potential to detect inflammatory changes in CF lung disease.
The main aims of our study were: 1) to explore the feasibility of DWI to detect lung inflammatory changes in CF patients, and 2) to correlate DWI with radiological and clinical indicators of CF lung disease severity.
Material and methods
In this multicenter prospective cross-sectional study, patients with CF scheduled for their routine annual evaluation were consecutively recruited in two Italian CF centres (Treviso and Rome) by their treating physicians. At the clinical evaluation, each patient was informed about the study and asked to participate. When willing to participate, the subject was scheduled for the study protocol within two weeks from the visit. The study was approved by the institutional review board in all participating centres (n. 292/AULSS9 and n. 419/09). All patients underwent a physical examination, spirometry, chest-CT, and chest-MRI on the same day. Inclusion and exclusion criteria are described in Table 1 .
Physical examination and spirometry
Informed consent was obtained, and each patient underwent a clinical examination, pulse oximetry, and spirometry, prior to imaging. As part of the clinical exam, heart and respiratory rate, weight and height were recorded. Spirometry was performed according to the ATS/ERS guidelines [24] .
CT and MRI protocol
The routine biennial CT protocol consisted of volumetric endinspiratory and end-expiratory low-dose scans in a 16-or 64-row scanner (SOMATOM Sensation, Siemens, Erlangen, Germany) using the following parameters: 120 kV for patients ≥ 35 kg,100 kV for patients < 35 kg, mAs 15-40, no contrast agent, 1 mm collimation, slice thickness 1 mm, reconstruction increment 0.8 mm, pitch 1. Five mm axial and coronal reformats with kernels B31f, B60f, and B70f were obtained to match the slice thickness of MR images.
In addition to the routine CT protocol a chest MRI was performed on the same day. The MRI protocol consisted of respiratory-triggered scans using a 16 channel torso coil in a clinical 1.5 T scanner, with the following parameters: axial and coronal BLADE sequence proton-density (PD)-weighted with navigator (TR/TE/alpha/: ∞/28 ms/90°, in plane resolution 1.2 × 1.2 mm and slice thickness 5 mm) and T2-weighted axial BLADE sequence (TR/TE/alpha = 2000 ms/ 27 ms/150°, in plane resolution 3.2 × 2.5 mm and slice thickness 5 mm). DWI was acquired using a single-shot echoplanar imaging sequence (EPI) in the axial plane, with gradients equal in all directions (readout, phase, and slicesection orientations). DWI was obtained with b values of 0 and 600 s/mm 2 (TR/TE/alpha = 5632 ms/83 ms/90°, slice thickness 5 mm, gap 0 mm, 2 average). All sequences were acquired at end-expiration during free-breathing using navigator echoes respiratory triggering. The MRI protocol was identical in both CF centres, which had the same MRI scanner (MAGNETOM Avanto, Siemens Healthcare, Erlangen, Germany).
Image analysis
All CT and MRI images were anonymized and evaluated in random order by two radiologists (P.C. and G.S.), with 4 years and 1 year of experience in thoracic CT and MRI scoring, respectively. Both radiologists were blinded to any clinical information and to each other's CT and MRI assessment. Prior to this study, both radiologists were trained in the CF center of Erasmus MC (Rotterdam, the Netherlands) to the CF-CT and CF-MRI scoring systems [25] , which were used to score the CT and BLADE MR images [26] .The total score is the sum of the individual sub-scores per lobe of the following parameters: bronchiectasis (CF-CT BE ); mucus plugging (CF-CT mucus ); air wall thickening (CF-CT AWT ); trapped air (CF-CT TA ), and parenchyma (CF-CT PAR ) [26] . Subscores and total scores are expressed as % of the maximal possible score.
DWI images were scored in random order using a semi-quantitative scoring approach, which has been used in previous studies [27] [28] [29] . This qualitatively analyzes the signal intensity of lung lesions with altered signal intensity (hotspots). Each hotspot was visually graded on a three-point score scale by signal intensity: score 0, no signal; score 1, weak signal and score 2, strong signal. Signal intensity was judged using the highest bvalue (b = 600 s/mm 2 ) images, compared to the signal of the spinal cord. Spinal cord was used as the reference structure as it has constant high signal intensity on high b values as a result of the anatomical organization of the sagittal nerve fascicles, and it is alongside the entire chest. When the DWI signal of lung parenchymal hotspots was lower than that of the cord, it was graded as Bweak^(DWI weak score , score = 1), whereas if the signal was greater than or equal to that of the cord it was graded as Bstrong^(DWI strong score , score = 2). The total DWI score (DWI total score ) is the sum of all weak and strong hotspots for each of the six lung lobes, with lingula considered a separate lobe. A quantitative analysis was not performed based on the poor reliability of the apparent diffusion coefficient (ADC) maps due to residual motion and susceptibility-induced distortions. Following DWI scoring, using fusion technique (Image Fusion, Siemens Healthcare, Erlangen, Germany) between DWI and correlated morphological image (axial BLADE), the anatomical substrate and the distribution of the DWI hotspots was identified. In uncertain cases, the CT was used as reference image. The percentage of structural CT changes presenting hotspots in DWI images was computed as a ratio between the DWI total score and the CF-CT total score . Anatomical substrates with DWI signal were categorized in a similar fashion to the CF-CT and CF-MRI scoring system (Online supplement digital content 1).
Statistical analysis
For each patient, the mean DWI score of the two observers was used to assess frequency and distribution of the anatomical substrates with DWI signal. Inter-observer agreement for the CF-CT, CF-MRI, and DWI scoring methods was assessed using the intraclass correlation coefficient (ICC) and BlandAltman plots. ICC values between 0.40-0.60; 0.60-0.80; and ≥ 0.80 are considered to represent moderate, good, and very good agreement, respectively.
Pearson's correlation was used to measure the strength of the association between DWI score and clinical and radiological parameters reflecting disease severity. These parameters included: forced expiratory volume in one second (FEV 1 % predicted); Body Mass Index (BMI); CF-CT BE ; CF-CT mucus ; and CF-CT total score . According to Cohen's criteria, BMI=Body Mass Index, CT-BE= Computed tomography bronchiectasis sub-score, CF-CT=Cystic Fibrosis Computed Tomography score, CTMucus= Computed tomography mucus plugs sub-score, DWI= Diffusion Weighted Imaging, FEV 1 %=Forced expiratory volume in one second % predicted. All CT score and sub-scores are expressed as a percentage of the maximum possible score, ranging from 0 (no pathological findings) to 100 (maximum severity). The maximum possible scores for CF-CT, CT-BE and CT-mucus sub-scores are 243, 72, and 36, respectively. DWI scores are expressed as mean score of the two observers for each patient correlations with r between 0.10 and 0.29 are considered weak, between 0.30 and 0.49 moderate and above 0.50 are strong [30] . Multiple comparisons were adjusted using the Bonferroni correction. Differences in continuous variables between patients with and without DWI hotspots were examined using a Student t-test.
Finally, data were analyzed using a mixed-effects models to investigate whether there was an association between specific covariates and the outcomes of interest, while accounting for the correlation within the same patients [31] . The covariates tested in the model were BMI, FEV 1 , sex, CF-CT BE, CF-CT mucus and score of each observer (score observer 1 versus Fig. 1 
observer 2). The outcome tested for these covariates were: DWI weak score , DWI strong score , and DWI total score . The Akaike information criterion (AIC) was used to investigate which model performs better [32] . The lowest AIC coefficient defines the best model for the given data, and differences in AIC coefficient greater than 5 points are considered significant [32] . Differences were statistically significant if p < 0.05. Statistical analysis was performed with SPSS (version 20.0, SPSS, Chicago, IL, USA) and R (version 3.1.3, the R foundation for statistical computing, Vienna, Austria).
Results
After 12 months of recruitment (April 2011-March 2012) period, thirty-eight consecutively selected patients with CF (mean age 24 years, range 6-51 years, 22 females) were enrolled in the study. Five subjects were excluded for incomplete study protocol, so eventually thirty-three patients with CF were used for data analysis. (mean age 21 years, range 6-51 years, 19 females). Patients' characteristics, CT and DWI scores are summarized in Table 2 .
Distribution and anatomical substrates of DWI signal
A mean number of 6 (SD 5.2, range 0-17.5) weak and 6.9 (SD 8.4, range 0-32) strong DWI hotspots were identified. DWI hotspots were distributed in decreasing order in the right upper lobe (mean 25.4 %, SD 8.4, range 0-37.9 %), right lower lobe (mean 24.7 %, SD 6.8, range 16.3-50 %), left lower lobe (mean 21.5 %, SD 6.9, range 10-36.7 %), left upper lobe (mean 13.5 %, SD 3.6, range 6.7-20.6 %), right middle lobe (mean 8.2 %, SD 5.4, range 0-18.2 %) and lingula (mean 6.7 %, SD 3.1, 1.5-13.3 %). The most frequent structural lung alterations as examined on axial BLADE with either weak or strong DWI signal were mucus plugging (mean 61 %, SD 35, range 0-100 %), followed by consolidation (mean 26.5 %, SD 16.8, range 0-54 %), and bronchiectasis (mean 12.5 %, SD 9.3, range 0-37.5 %). The DWI hotspots pattern only partially overlapped the structural lung changes on morphological MRI or CT, and only 4 % (SD 2.6, range 1.5-12.9 %) of total CF-CT structural lung changes presented DWI hotspots.
Reliability of DWI score
Overall, inter-observer agreement for CF-CT and CF-MRI sub-scores was good or very good, except for the trapped-air sub-score. ICCs for CF-CT and CF-MRI are presented as a table in the online supplement digital content 2 BLINDED . Interobserver agreements for DWI weak score , DWI strong score , and DWI total score were good: ICC 0.76 (C.I. 95 %, 0.55-0.87), 0.74 (C.I. 95 %, 0.43-0.87) and 0.7 (C.I. 95 %, 0.04-0.89), respectively. Bland-Altman and identity plots showed that observer 2 had systematically higher DWI total score scores than observer 1 (Fig. 1) . Bland-Altman and identity plots for total DWI hotspots identified by each observer are presented as online supplement digital content 3. 
Correlations of DWI signal with clinical and radiological parameters
Total DWI score had strong positive correlation with CF-CT BE (r = 0.757 observer 1, r = 0.510 observer 2), CT mucus (r = 0.759 observer 1, r = 0.584 observer 2) sub-scores, and CF-CT total score (r = 0.790 observer 1, r = 0.618 observer 2) (Fig. 3) . DWI total score had strong negative correlation with FEV 1 (r = − 0.688 observer 1, r = −0.611 observer 2) (Fig. 2) : FEV 1 in patients without DWI hotspots (n = 11) was significantly higher (p < 0.0001) than those of patients with DWI hotspots. BMI did not correlate with DWI total score and no significant differences in BMI were found between the groups with or without hotspots.
Relationship of covariates in DWI scores: mixed-effects models
For the DWI strong outcome, the model with the covariate CF-CT mucus (AIC = 398.6) was better than the model with FEV 1 (AIC = 406.2). However, there were no significant differences in AIC coefficient between the model with FEV 1 or CF-CT mucus covariates when tested for the DWI weak and DWI total score outcomes (DWI weak : AIC-FEV 1 = 367.4, AIC-CF-CT mucus = 368; DWI total score : AIC-FEV 1 = 447, AIC-CF-CT mucus = 446.9). Therefore, we considered the best predictive model for all three DWI outcomes (weak, strong, and total DWI) that including CF-CT mucus but not FEV 1 . The final model included the covariates: BMI, gender, observer score, CF-CT BE , and CF-CT mucus . In this model the CF-CT mucus and observer score covariates were significant for the DWI strong , and for DWI total score . For the DWI weak score outcome, the CF-CT BE covariate was significant, while CF-CT mucus tended to be significant (p = 0.052). Mixed-effects models results are summarized in Table 3 . Figure 3 shows effect plots for each DWI score outcome (DWI weak score , DWI strong score , and DWI total score ) based on the mixed-effects model analysis.
Discussion
To our knowledge, this is the first study that has used DWI to assess CF lung disease, and several observations can be made from these results.
The most important observation is that DWI hotspots only partially overlapped the structural lung changes as seen on morphological CT or MRI (Fig. 4) . Moreover, the DWI signal for the same parenchymal abnormality on MRI in a single patient was very different. For instance, mucous plug as observed on MRI in a lobe could show different signal intensities, from no signal to a very intense signal (Fig. 5) . Similar variability was also observed for other structural lung changes, such as consolidation and bronchiectasis, which were the most frequent structural lung changes presenting a DWI signal. We speculate that the observed differences in DWI signal intensity might be related to the severity of local inflammation, based on differences in the cellularity of the structure examined and consequently in differences in the restriction of proton movement.
Alternative explanations are that increased DWI signal intensity depend on an increased capillary perfusion in relation to inflammation, which can be detected by DWI as D* (pseudo-diffusion coefficient) associated with blood flow [33] . However, pseudo-diffusion was not assessed in our MRI protocol, as intravoxel incoherent motion imaging was not applied [34] . Furthermore, differences in DWI signal intensity (weak vs. strong) among the structural lung changes could be related to differences in water concentrations caused by T2-shinethrough artefact [35] . To overcome this, we assessed 1 = Forced expiratory Volume in 1 second % of predicted, SE= Standard Error. Note significant differences in observer score (scores observer 1 vs. observer 2) and CF-CT mucus covariates for DWI strong score and DWI total score outcomes (*). For the DWI weak score outcome, the CF-CT BE is significant (*), while CF-CT mucus tends to be significant and scored the DWI images in the highest b-value (b = 600 s/mm 2 ), with reduced T2-shine-through effect (Fig. 5) .
The second important finding is that DWI scores correlated well with radiological and clinical indicators of CF lung disease severity. DWI scores had a strong positive correlation with CF-CT score and a moderate negative correlation with FEV 1 . In particular, the higher the DWI score, the higher the CF-CT score, or the lower the FEV 1 . These correlations suggest that patients with more severe CF lung disease have a larger number of DWI hotspots. This observation is also supported by the findings that there were significant differences in FEV 1 between patients with and without DWI hotspots.
The third important observation is from the mixedeffects model, which shows that for the DWI strong outcome, the best model (lowest AIC coefficient) was the model that included the CF-CT mucus sub-score instead of the FEV 1 covariate. DWI strong score represents those hotspots with high DWI signal, which suggests a restricted diffusion. Paired with the finding that mucus was also the most frequent alteration associated with DWI signal, it suggests that mucus significantly contributes to the Binflammatory^DWI hotspots in CF lung disease. This is not unlikely as reduced mucus clearance is considered to be the primary cause of chronic airway infection and inflammation in CF [1] .
We acknowledge some limitations to this study. First, we used a semi-quantitative scoring system to assess DWI signal and did not compute ADC maps. The main reason was that the ADC maps were not reliable due to residual motion and susceptibility-induced distortions. Part of these distortion artefacts was counterbalanced by doubling the number of averages during image acquisition. More than two averages combined with respiratory-triggered acquisition were not feasible, as it would have led to unacceptably long acquisition times of the DWI sequence (>10 minutes). For these reasons, we used a semi-quantitative approach that has proved to be reliable in previous studies, with high sensitivity and specificity [29] . Moreover, this method showed good agreement between the observers. Second, there were significantly different scores between the observers as shown by the Bland-Altman plots and by the mixed model analysis (observer score covariate). However, correlations using the individual Fig. 3 Effects plots for diffusion-weighted imaging (DWI) scores outcomes (a) weak, (b) strong, and (c) total DWI score; and CF-CT mucus covariate. Each plot has two curves, one for each observer. Y-axis represents DWI scores while x-axis the CF-CT mucus sub-score expressed as % of maximum score, which is 36 for mucus. Each plot simulates changes in CF-CT mucus sub-score according DWI scores for patients with mean BMI, mean CF-CT BE sub-score and male gender. For instance, an increase of about 10 % in CF-CT mucus sub-score (c) produces an increase of DWI total score of almost 3 points. Note that, although observer 2 has overall higher total DWI scores (c); the slope of the relation between DWI total score and CF-CT mucus sub-score is the same as for observer 1 scores of each observer instead of taking the mean scores of both observers obtained the same significant and concordant results (Table 3) . Hence, it is unlikely that the differences in scores between the observers had any impact on our most important findings. The development of a fully quantitative approach will overcome this inter-observer limitation, by providing objective ADC maps that are independent of observer variability. For now, we are improving the image quality of our DWI protocol, to facilitate the use of ADC maps for future studies.
Finally, we did not objectively assess the exact nature of these DWI hotspots. However, our study had the main aim to investigate the information obtainable with DWI in CF lung disease. Clearly, further studies are needed to validate this technique in CF patients suffering from a pulmonary tract exacerbation. 
Conclusions
In summary, this study is the initial exploratory phase towards the development of DWI as a technique to quantify lung inflammation in CF lung disease. We observed that the DWI hotspots pattern only partly overlapped structural abnormalities on morphological CT or MRI. In addition, DWI scores had a strong correlation with radiological and clinical indicators of CF lung disease severity. Significant differences in pulmonary function (FEV 1 ) were found between patients without and with DWI hotspots. Finally, we found that the amount of mucus in patients with CF was the best predictor of strong DWI hotspots (restricted diffusion).
These compelling results have established the foundations for future validation studies in CF patients with pulmonary exacerbation, to establish the exact nature of these DWI hotspots.
